Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications
- PMID: 27401327
- DOI: 10.1016/j.jconrel.2016.07.012
Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications
Abstract
To optimally exploit the potential of (tumor-) targeted nanomedicines, platform technologies are needed in which physicochemical and pharmaceutical properties can be tailored according to specific medical needs and applications. We here systematically customized the properties of core-crosslinked polymeric micelles (CCPM). The micelles were based on mPEG-b-pHPMAmLacn (i.e. methoxy poly(ethylene glycol)-b-poly[N-(2-hydroxypropyl) methacrylamide-lactate]), similar to the block copolymer composition employed in CriPec® docetaxel, which is currently in phase I clinical trials. The CCPM platform was tailored with regard to size (30 to 100nm), nanocarrier degradation (1month to 1year) and drug release kinetics (10 to 90% in 1week). This was achieved by modulating the molecular weight of the block copolymer, the type and density of the crosslinking agent, and the hydrolytic sensitivity of the drug linkage, respectively. The high flexibility of CCPM facilitates the development of nanomedicinal products for specific therapeutic applications.
Keywords: Core-crosslinking; Drug release; Drug targeting; Nanomedicine; Polymeric micelles.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles.Adv Drug Deliv Rev. 2022 Dec;191:114613. doi: 10.1016/j.addr.2022.114613. Epub 2022 Nov 4. Adv Drug Deliv Rev. 2022. PMID: 36343757 Review.
-
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.Biomaterials. 2010 Oct;31(30):7797-804. doi: 10.1016/j.biomaterials.2010.07.005. Epub 2010 Jul 31. Biomaterials. 2010. PMID: 20673684
-
HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.Eur J Pharm Biopharm. 2015 Aug;94:501-12. doi: 10.1016/j.ejpb.2015.06.010. Epub 2015 Jun 30. Eur J Pharm Biopharm. 2015. PMID: 26134273
-
Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.Biomaterials. 2009 Jun;30(16):3009-19. doi: 10.1016/j.biomaterials.2009.02.011. Epub 2009 Feb 27. Biomaterials. 2009. PMID: 19250665
-
[Progress in the study of core-crosslinked polymeric micelles in drug delivery system].Yao Xue Xue Bao. 2014 Feb;49(2):183-9. Yao Xue Xue Bao. 2014. PMID: 24761607 Review. Chinese.
Cited by
-
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects.J Nanobiotechnology. 2023 Jul 22;21(1):232. doi: 10.1186/s12951-023-01992-2. J Nanobiotechnology. 2023. PMID: 37480102 Free PMC article. Review.
-
Versatile Click Linker Enabling Native Peptide Release from Nanocarriers upon Redox Trigger.Bioconjug Chem. 2023 Dec 20;34(12):2375-2386. doi: 10.1021/acs.bioconjchem.3c00484. Epub 2023 Dec 11. Bioconjug Chem. 2023. PMID: 38079189 Free PMC article.
-
Orthogonal Covalent Entrapment of Cargo into Biodegradable Polymeric Micelles via Native Chemical Ligation.Biomacromolecules. 2023 Oct 9;24(10):4385-4396. doi: 10.1021/acs.biomac.2c00865. Epub 2022 Aug 31. Biomacromolecules. 2023. PMID: 36044412 Free PMC article.
-
Effect of Formulation and Processing Parameters on the Size of mPEG- b-p(HPMA-Bz) Polymeric Micelles.Langmuir. 2018 Dec 18;34(50):15495-15506. doi: 10.1021/acs.langmuir.8b03576. Epub 2018 Nov 26. Langmuir. 2018. PMID: 30415546 Free PMC article.
-
Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles.J Control Release. 2020 Dec 10;328:805-816. doi: 10.1016/j.jconrel.2020.09.046. Epub 2020 Sep 30. J Control Release. 2020. PMID: 33010332 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources